Apotex Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APOTEX INC, and what generic and branded alternatives to APOTEX INC drugs are available?
APOTEX INC has one hundred and five approved drugs.
There are thirteen tentative approvals on APOTEX INC drugs.
Summary for Apotex Inc
| US Patents: | 0 |
| Tradenames: | 83 |
| Ingredients: | 80 |
| NDAs: | 105 |
| Drug Master File Entries: | 2 |
| Patent Litigation for Apotex Inc: | See patent lawsuits for Apotex Inc |
| PTAB Cases with Apotex Inc as petitioner: | See PTAB cases with Apotex Inc as petitioner |
Drugs and US Patents for Apotex Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Inc | GALANTAMINE HYDROBROMIDE | galantamine hydrobromide | TABLET;ORAL | 077781-001 | Sep 27, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Apotex Inc | OLANZAPINE | olanzapine | TABLET;ORAL | 090798-004 | Apr 23, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apotex Inc | VALSARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; valsartan | TABLET;ORAL | 203026-003 | Mar 21, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
